Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

Titeler, M., Lyon, R.A., Glennon, R.A.·1988·Psychopharmacology
DOI 10.1007/bf00176847

Cited by (351)

Items 301–351 of 351

  1. In Vitro Screening of Psychoactive Drugs to Prevent the Abuses
    Kanako Satoh, Ryouichi Nonaka · 2008 · YAKUGAKU ZASSHI
  2. Psychosis in Parkinson’s Disease and Current Management Trends- an Updated Review of Literature
    Rajib Dutta · 2023 · Journal of Neuroscience and Neurological Disorders
  3. Serotonin and serotonin receptors in hallucinogen action
    Adam L. Halberstadt, David E. Nichols · 2020 · Handbook of behavioral neuroscience
  4. Substance Abuse: Hallucinogen‐ and MDMA‐Related Disorders
    Rif S. El‐Mallakh, John H. Halpern, Henry David Abraham · 2015 · Wiley eBooks
  5. Neuroendocrinological Effects of MDMA in the Rat
    J. Frank Nash, Herbert Y. Meltzer · 1990 · Topics in the neurosciences
  6. Chapter 5 Advances in Central Serotonergics
    Håkan Wikström, Kjell A. Svensson · 1990 · Annual reports in medicinal chemistry
  7. The utility of 2,5-dimethoxy-4-iodoamphetamine for the study of serotonin 2A and 2C receptors
    Lindsay P. Cameron, Alaina M. Jaster, Raul Ramos, Elijah Z. Ullman · 2025 · Molecular Pharmacology
  8. Effects of congeners of amphetamine on the human heart
    Joachim Neumann, Stefan Dhein, Uwe Kirchhefer, Britt Hofmann, Ulrich Gergs · 2024 · Naunyn-Schmiedeberg s Archives of Pharmacology
  9. Low (micro)doses of 2,5-dimethoxy-4-propylamphetamine (DOPR) increase effortful motivation in low-performing mice
    Michael N. Noback, Johnny A. Kenton, Adam K. Klein, Zoë A. Hughes, Andrew C. Kruegel, Yasmin Schmid, Adam L. Halberstadt, Jared W. Young · 2025 · Neuropharmacology
  10. Appraisal of the validity of preclinical investigations to predict the efficacy of psychedelic drugs as fast-acting antidepressants
    S. Clare Stanford · 2025 · Journal of Psychopharmacology
  11. Identification of structural determinants of ligand selectivity in 5-HT2 receptor subtypes on the basis of protein–ligand interactions
    Jae Wan Jang, Min Sup Kim, Yong Seo Cho, Art E. Cho, Ae Nim Pae · 2012 · Journal of Molecular Graphics and Modelling
  12. Magnesium in drug abuse and addiction
    M Nechifor · 2011 · University of Adelaide Press eBooks
  13. PREDICTION OF ANTIPSYCHOTIC ACTIVITY
    Nadia M.J. Rupniak, Susan D. Iversen · 1993 · Elsevier eBooks
  14. The 5-HT2-type receptor family
    Eric Ronken, Berend Olivier · 1997 · Pharmacochemistry library
  15. The Psychopharmacology of Hallucinations: Ironic Insights into Mechanisms of Action
    Nicole Gellings Lowe, Maria Paola Rapagnani, Chiara Mattei, Stephen M. Stahl · 2012 · Springer eBooks
  16. Topiramate-induced Dissociative Disorder.
    Sajjad R Sarwar, McGinnis Ra · 2011 · Europe PMC (PubMed Central)
  17. Drugs of Abuse Affecting 5-HT2B Receptors
    Dino Luethi, Matthias E. Liechti · 2021 · The Receptors
  18. Contributions of Traumatic Stress Studies to the Neurobiology of Dissociation and Dissociative Disorders: Implications for Schizophrenia
    Eric H. G. J. M. Vermetten, Ruth A. Lanius, J. Douglas Bremner · 2008 · Wiley eBooks
  19. Psychedelics and the Serotonin Hypothesis of Eating Disorders
    Dean Bilenker, Nicole M. Avena · 2025 · Brain Sciences
  20. Substances of Abuse and Hallucinogenic Activity: The Serotoninergic Pathway - Focus on Classical Hallucinogens and Entactogens
    Matteo Lazzaretti, Gian Mario Mandolini, Alfredo Carlo Altamura, Paolo Brambilla · 2018 · Springer eBooks
  21. Persönlichkeits- und Impulskontrollstörungen — Neurobiologie
    Christian G. Schmahl, Martin Bohus · 2006 · Springer eBooks
  22. Class A GPCR: Serotonin Receptors
    Ellinor Grinde, Katharine Herrick‐Davis · 2017 · Springer eBooks
  23. Ätiopathogenese und Neurobiologie
    Kathlen Priebe, Christian G. Schmahl, Christian Stiglmayr · 2013 · Springer eBooks
  24. Health education of the public: its role in the eradication of vector-borne disease.
    H P Gillette · 1963 · PubMed Central
  25. Investigating the antinociceptive effects of N-docosahexaenoyl ethanolamine and novel kappa opioid receptor agonists
    Kelly F. Paton · 2018
  26. Animal Models and Procedures for CNS Disorders
    Neal R. Cutler, John J. Sramek, Michael F Murphy, Henry Riordan, P. R. Bieck, Angelico Carta · 2010 · Wiley eBooks
  27. Where Structure Meets Function
    David R. Sibley, Bryan L. Roth, David L. Willins, Kurt Kristiansen, Wesley K. Kroeze · 1998
  28. The Discovery of Multiple Serotonin Receptor Subtypes: A Lesson from Molecular Cloning to Functional Expression
    Milt Teitler · 2007 · Springer eBooks
  29. Papel dos receptores 5-HT2a e 5-HT2c da matéria cinzenta periaquedutal nas reações de defesa em camundongos: influência da experiência prévia ao teste e do modelo empregado
    Karina Santos Gomes · 2009 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  30. Synthesis of Serotonin Agonists as 5-HT2A and 5-HT2C Receptor Molecular Probes
    Dani M. Schultz · 2006
  31. Experimental Research
    Pau Celada, Anna Castañé, Albert Adell, Francesc Artigas · 2007 · Wiley eBooks
  32. Other Times I Can Barely See: The Effects of Hallucinogens on Vision and Attention
    Matthew J. Baggott · 2010 · eScholarship (California Digital Library)
  33. Lysergic Acid Diethylamide and Mescaline
    2014 · John Wiley & Sons, Inc. eBooks
  34. Hallucinogens
    Stephen J. Traub · 2007 · Elsevier eBooks
  35. Substance Use and Substance Use Disorders
    Kenneth J. Sher, William E. Conlin, Robert O. Pihl · 2023 · Oxford University Press eBooks
  36. LSD (Lysergic Acid Diethylamide)
    Jayalakshmi Krishnan · 2024 · BENTHAM SCIENCE PUBLISHERS eBooks
  37. Hallucinogen Use Disorder
    Nathen A. Spitz · 2025 · Springer eBooks
  38. Neuroimaging of MDMA-Induced Neurotoxicity
    Una D. McCann, Zsolt Roland Szabó, George A. Ricaurte · 2002 · Humana Press eBooks
  39. Le test-retest dans un modèle animal d'anxiété chez la souris : sensibilisation, discrimination dans le test des quatre-plaques
    Nadège Ripoll · 2005 · OpenGrey (Institut de l'Information Scientifique et Technique)
  40. Дисрегуляція моноамінергічних систем як об’єкт цільової терапії посттравматичного стресового розладу. Частина 1: серотонінергічна дисфункція при посттравматичному стресовому розладі та перспективні засоби її фармакологічної корекції
    О. Є. Ядловський, С. О. Мисливець, С. С. Таніна, Т. А. Бухтіарова · 2026 · Pharmacology and Drug Toxicology
  41. Rôle des récepteurs 5-HT2A et 5-HT6 du cortex préfrontal dans la modulation de la transmission synaptique, la plasticité et la cognition
    Coralie Berthoux · 2017 · theses.fr (ABES)
  42. Le récepteur métabotropique du glutamate mGlu2 interagit avec et transactive le récepteur tyrosine kinase TrkB : rôle dans la réponse comportementale aux antipsychotiques glutamatergiques
    Clémentine Eva Philibert · 2022 · theses.fr (ABES)
  43. BindingDB Entry 50010413: Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.
    BindingDB · 2009 · UC San Diego
  44. BindingDB Entry 50049209: The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The"Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.
    BindingDB · 2019 · UC San Diego
  45. BindingDB Entry 50007222: Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
    BindingDB · 2009 · UC San Diego
  46. BindingDB Entry 5272: Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors.
    BindingDB · 2012 · UC San Diego
  47. BindingDB Entry 50006677: Dihydrobenzofuran analogues of hallucinogens. 3. Models of 4-substituted (2,5-dimethoxyphenyl)alkylamine derivatives with rigidified methoxy groups.
    BindingDB · 2009 · UC San Diego
  48. BindingDB Entry 50007457: Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA).
    BindingDB · 2009 · UC San Diego
  49. BindingDB Entry 50016559: Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands.
    BindingDB · 2009 · UC San Diego
  50. BindingDB Entry 5232: Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells.
    BindingDB · 2012 · UC San Diego
  51. Untitled work
    Cornea-Hébert · 1999 · 10.1002/(sici)1096-9861(19990628)409:2